Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models

BMC Medical Imaging

Volumn 15, Issue 1, 2015, Pages

  Khalvati, Farzad ^a,b   Wong, Alexander ^c   Haider, Masoom A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Canada   (Canada)

^c UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; EARLY CANCER DIAGNOSIS; HUMAN; MALE; PROCEDURES; PROSTATIC NEOPLASMS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; DIFFUSION MAGNETIC RESONANCE IMAGING; EARLY DETECTION OF CANCER; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84939428004     PISSN: None     EISSN: 14712342     Source Type: Journal    
DOI: 10.1186/s12880-015-0069-9     Document Type: Article

References (59)

1. Canadian Cancer Society. Canadian Cancer Statistics. 2014. http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2014--EN.pdf .
2. American Cancer Society. Cancer Facts and Figures. 2014. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/ .
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A Cancer J Clin. 2011; 61(2):69-90.
4. Canadian Cancer Society. Canadian Cancer Statistics. 2011. http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2011-EN.pdf .
5. Andriole GL, Crawford D, Grubb RL, Buys SS, Chia D, Church TR, et al. PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360:1310-9.
6. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360:1320-8.
7. Greene KL, Albertsen PC, Babaian RJ, Albertsen PC, Carter HB, Gann PH, et al. Prostate Specific Antigen Best Practice Statement 2009 Update. J Urol. 2009; 182(5):2232-41.
8. Vickers AJ, Sjoberg DD, Ulmert D, Vertosick E, Roobol MJ, Thompson I, et al. Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen. BMC Medicine. 2014; 12:26.
9. Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013; 64(6):876-92.
10. Schroder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, et al. ERSPC Investigators. "Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012; 366(11):981-90.
11. Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. Division of Urology, Sunnybrook Research Institute. 2013. doi: 10.1016/j.juro.2009.11.043 .
12. Arumainayagam N, Ahmed HU, Moore CM, Freeman A, Allen C, Sohaib SA, et al. Multiparametric MR Imaging for Detection of Clinically Significant Prostate Cancer: A Validation Cohort Study with Transperineal Template Prostate Mapping as the Reference Standard. Radiology. 2013; 268(3):761-769.
13. Tiwari P, Kurhanewicz J, Madabhushi A. Multi-kernel graph embedding for detection, gleason grading of prostate cancer via MRI-mrs. Med Image Anal. 2013; 17:219-35.
14. Glaister J, Cameron A, Wong A, Haider MA. Quantitative investigative analysis of tumour separability in the prostate gland using ultra-high b-value computed diffusion imaging. In: EMBC'2012: 2012. p. 420-423. doi: 10.1109/EMBC.2012.6345957 .
15. Ozer S, Haider MA, Langer DL, van der Kwast TH, Evans AJ, Wernick MN, et al. Prostate cancer localization with multispectral MRI based on relevance vector machines. In: 2009 IEEE International Symposium on Biomedical Imaging From Nano to Macro: 2009. p. 73-76. doi: 10.1109/ISBI.2009.5192986.
16. Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol. 2011; 186:1818-24.
17. Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi A, Lockwood G, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol. 2007; 189(2):323-8.
18. Langer DL, van der Kwast TH, Evans AJ, Plotkin A, Trachtenberg J, Wilson BC, et al. Prostate Tissue Composition and MR Measurements: Investigating the Relationships between ADC, T2, K-trans, v-e, and Corresponding Histologic Features. Radiology. 2010; 255(2):485-94.
19. Vourganti S, Rastinehad A, Yerram NK, Nix J, Volkin D, Hoang A, et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol. 2012; 188:2152-7.
20. Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, et al. Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol. 2012; 188:1157-63.
21. Tan CH, Wei W, Johnson V, Kundra V. Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol. 2012; 199:822-829.
22. Oto A, Kayhan A, Jiang Y, Tretiakova M, Yang C, Antic T, et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology. 2010; 257:715-23.
23. Shigemura K, Yamanaka N, Yamashita M. Can diffusion-weighted magnetic resonance imaging predict a high Gleason score of prostate cancer?Korean J Urol. 2013; 54:234-38.
24. Caivano R, Rabasco P, Lotumolo A, Cirillo P, D'Antuono F, Zandolino A, et al. Comparison between Gleason score and apparent diffusion coefficient obtained from diffusion-weighted imaging of prostate cancer patients. Cancer Invest. 2013; 31:625-9.
25. Bae H, Yoshida S, Matsuoka Y, Nakajima H, Ito E, Tanaka H, et al. Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. Int Urol Nephrol. 2014; 46(3):555-61.
26. Nagarajan R, Margolis D, Raman S, Sheng K, King C, Reiter R, et al. Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer. Adv Urol. 2012; 2012:374805.
27. Bittencourt LK, Barentsz JO, de Miranda LC, Gasparetto EL. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol. 2012; 22:468-75.
28. Langer DL, van der Kwast TH, Evans AJ, Sun L, Yaffe MJ, Trachtenberg J, et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers. Radiology. 2008; 249:900-8.
29. Madabhushi A, Feldman MD, Metaxas DN, Tomaszeweski J, Chute D. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI. IEEE Trans Med Img. 2005; 24(12):1611-25.
30. Litjensa GJS, Elliottb R, Shihc N, Feldmanc M, Barentsza JO, Hulsbergen - van de Kaaa CA, et al. Distinguishing prostate cancer from benign confounders via a cascaded classifier on multi-parametric MRI. Medical Imaging. 2014. doi: 10.1117/12.2043751.
31. Vos PC, Barentsz JO, Karssemeijer N, Huisman HJ. Automatic computer-aided detection of prostate cancer based on multiparametric magnetic resonance image analysis. Phys Med Biol. 2012; 57:1527-42.
32. Haralick RM, Shanmugan K, Dinstein I. Textural features for image classification. IEEE Trans Syst Man Cybern. 1973; SMC-3:610-21.
33. Soh L, Tsatsoulis C. Texture Analysis of SAR Sea Ice Imagery Using Gray Level Co-Occurrence Matrices. IEEE Trans Geosci Remote Sensing. 1999; 37(2). doi: 10.1109/36.752194 .
34. Gabor D. Theory of communication. J Inst Electr Eng. 1946; 93:429-41.
35. Kirsch RA. Computer determination of the constituent structure of biological images. Comput Biomed Res. 1971; 4:315-28.
36. Chen C, Daponte JS, Fox MD. Fractal feature analysis and classification in medical imaging. IEEE Trans Med Imag. 1989; 8(2):133-42.
37. Galloway MM. Texture analysis using gray level run lengths. Comp Graph Im Proc. 1975; 4(2):172-9.
38. Khayam SA. The Discrete, Cosine Transform (DCT): Theory and Application: Department of Electrical & Computer Engineering, Michigan State University; 2003.
39. Duda D, Kretowski M, Mathieu R, Crevoisier RD, Bezy-Wendling J. Multi-Image Texture Analysis in Classification of Prostatic Tissues from MRI. Preliminary Results. Information Technologies in Biomedicine, 139 Volume 3, Advances in Intelligent Systems and Computing 283, 2014. doi: 10.1007/978-3-319-06593-9_13.
40. Peng H, Long F, Ding C. Feature selection based on mutual information criteria of maxdependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell. 2005; 27:1226-38.
41. Tipping ME. Sparse Bayesian learning and the relevance vector machine. J Mach Learn Res. 2001; 1:211-244.
42. Wong A, Glaister J, Cameron A, Haider M. Correlated Diffusion Imaging. BMC Medical Imaging. 2013:13-26. doi: 10.1186/1471-2342-13-26.
43. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, et al.Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012; 48(4):441-6. doi: 10.1016/j.ejca.2011.11.036 .
44. Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014; 5:4006.
45. Gevaert O, Xu J, Hoang CD, Leung AN, Xu Y, Quon A, et al.Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data-methods and preliminary results. Radiology. 2012; 264(2):387-96. doi: 10.1148/radiol.12111607, 2012.
46. Khalvati F, Modhafar A, Cameron A, Wong A, Haider MA. Multi-Parametric Diffusion Magnetic Resonance Imaging Texture Feature Model for Prostate Cancer Analysis. International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI), Computational Diffusion MRI Workshop. Boston, Mass., USA: 2014. p. 79-88.
47. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012; 22(4):746-57 22:746-757, 2012.
48. Portalez D, Mozer P, Cornud F, Renard-Penna R, Misrai V, Thoulouzan M, et al. "Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol. 2012; 62(6):986-96. doi: 10.1016/j.eururo.2012.06.044 Epub.
49. Koh DM, Padhani AR. Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. Br J Radiol. 2006; 79:633-5.
50. Rosenkrantz AB, Taneja SS. Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol. 2014; 202:109-20.
51. Shafiee MJ, Haider SA, Wong A, Lui D, Cameron A, Modhafar A, et al. Apparent Ultra-High b-value Diffusion-Weighted Image Reconstruction via Hidden Conditional Random Fields. IEEE Trans Med Imaging. 2015; 34(5):1111-24.
52. Chang C, Lin C. LIBSVM: A library for support vector machines. ACM Trans Intell Syst Technol. 2011; 2(3):27:1-27:27.
53. Ozer S, Langer DL, Liu X, Haider MA. Supervised and unsupervised methods for prostate cancer segmentation with multispectral MRI. Med Phys. 2010; 37(3):1873-83.
54. Rezaeilouyeh H, Mahoor MH, Zhang J, La Rosa FG, Chang S, Werahera PN. Diagnosis of Prostatic Carcinoma on Multiparametric Magnetic Resonance Imaging Using Shearlet Transform. In: 36 th Intenational Conference of the IEEE Engineering In Medicine and Biology Society (EMBC): 2014. p. 6442-6445. doi: 10.1109/EMBC.2014.6945103.
55. Hambrock T, Vos PC, Hulsbergen-van de Kaa CA, Barentsz JO, Huisman HJ. Prostate Cancer: Computer-aided Diagnosis with Multiparametric 3-T MR Imaging-Effect on Observer Performance. Radiology. 2013; 266:521-30.
56. Wong A, Khalvati F, Haider MA. Dual-Stage Correlated, Diffusion Imaging. International Symposium on Biomedical Imaging. Brooklyn, NY, USA; 2015, pp. 75-78.
57. Cameron A, Modhafar A, Khalvati F, Lui D, Shafiee MJ, Wong A, et al.Multi-Parametric MRI Prostate Cancer Analysis via a Hybrid Morphological-Textural Model. In: International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). Chicago, Ill., USA: 2014. p. 3357-3360.
58. Cho DS, Khalvati F, Wong A, Haider MA. Prostate DWI Co-Registration via Maximization of Hybrid Statistical Likelihood and Cross-Correlation for Improved ADC and Computed Ultra-High b-value DWI Calculation. In: Proceedings of International Society for Magnetic Resonance in Medicine (ISMRM). Toronto, ON, Canada: 2015. p. 3748.
59. Khalvati F, Wong A, Bjarnason GA, Haider MA. Semi-Automatic Normalized Entropy Characterization of Metastatic Renal Cell Cancer via Spatio-Textural Tumour Classification. In: International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). Chicago, Ill., USA: 2014.